Exchange: NASDAQ·Updated 07:30 PM EDT

About

Adlai Nortye Group Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
109

Frequently Asked Questions

What is Market Cap of Adlai Nortye Group Ltd. - ADR?
What is the 52-week high for Adlai Nortye Group Ltd. - ADR?
What is the 52-week low for Adlai Nortye Group Ltd. - ADR?
What is Adlai Nortye Group Ltd. - ADR stock price today?
What was Adlai Nortye Group Ltd. - ADR stock price yesterday?
What is the PE ratio of Adlai Nortye Group Ltd. - ADR?
What is the Price-to-Book ratio of Adlai Nortye Group Ltd. - ADR?
What is the 50-day moving average of Adlai Nortye Group Ltd. - ADR?
How many employees does Adlai Nortye Group Ltd. - ADR have?

Advertisement|Remove ads.